Meet biotech leaders in Europe

You will meet a “who’s who” of the biopharma industry, including executives and investors from:

  • 4Bio Capital
  • Abingworth
  • AbbVie Ventures
  • Adbio Partners
  • Advent Life Sciences
  • Angelini Ventures
  • Argenx
  • Asabys Partners
  • Aulis Capital
  • Bioqube Ventures
  • BioGeneration Ventures
  • BlackRock
  • Bloom Burton & Co.
  • Blue Owl Capital
  • Boehringer Ingelheim Venture Fund
  • Bpifrance Investissement
  • Brandon Capital Partners
  • British Patient Capital
  • Caixa Capital
  • Cambridge Innovation Capital
  • Chugai Venture Fund
  • ClavystBio
  • Daiichi Sankyo
  • Digitalis Ventures
  • Droia Ventures
  • Eli Lilly
  • European Investment Fund (EIF)
  • Forbion
  • Forty51 Ventures
  • Frazier Life Sciences
  • Gilde Healthcare
  • Hadean Ventures
  • High-Tech Gründerfonds
  • HSBC
  • I&I Biotech Fund
  • Inveready Asset Management
  • Indaco Venture Partners
  • Ipsen
  • Jeito Capital
  • Johnson & Johnson
  • JP Morgan
  • Kurma Partners
  • Leerink Partners
  • Lightspeed Venture Partners
  • Lightstone Ventures
  • Lundbeckfonden BioCaptial
  • M Ventures
  • Medicxi
  • Merck KGaA
  • Monograph Capital
  • MSD/Merck
  • Novartis Venture Fund
  • Novo Holdings
  • Ono Venture Investment
  • Organon
  • Otsuka Pharmaceutical
  • Oxford Science Enterprises
  • Panacea Venture
  • Panakes Partners
  • PMV
  • Pureos Bioventures
  • Qiming Venture Partners
  • Quan Capital
  • Roche
  • Rosetta Capital
  • Sanofi
  • Seroba Lifesciences
  • Servier
  • Sofinnova Partners
  • Sound Bioventures
  • Sunstone Life Science Ventures
  • SV Health Investors
  • Syncona Investment Management
  • Taiho Ventures
  • Thuja Capital
  • UCB Ventures
  • V-Bio Ventures
  • VIB
  • XGen Venture
  • Wellington Partners
  • WuXi Biologics
  • And many more…